Rare and natural PPARγ mutations have been associated with insulin resistance, hypertension, and vascular hypertrophy [12–14], with the majority of mutations reported to date found in the ligand-binding domain (LBD) of the receptor [15]. Here, PPARG is linked to hypertensive disorder.